Yeşim Sağlıcan

550 total citations
45 papers, 288 citations indexed

About

Yeşim Sağlıcan is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Yeşim Sağlıcan has authored 45 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 18 papers in Rheumatology and 14 papers in Surgery. Recurrent topics in Yeşim Sağlıcan's work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (16 papers) and Urologic and reproductive health conditions (13 papers). Yeşim Sağlıcan is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (16 papers) and Urologic and reproductive health conditions (13 papers). Yeşim Sağlıcan collaborates with scholars based in Türkiye, United States and Greece. Yeşim Sağlıcan's co-authors include Ömer Acar, Tarık Esen, Ali Rıza Kural, Mustafa Bilal Tuna, Ercan Karaarslan, Mehmet Onur Demirkol, Metin Vural, Sergin Akpek, Ümit İnce and İlter Tüfek and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and BioMed Research International.

In The Last Decade

Yeşim Sağlıcan

41 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yeşim Sağlıcan Türkiye 9 200 103 69 44 36 45 288
François‐Xavier Nouhaud France 11 282 1.4× 77 0.7× 58 0.8× 110 2.5× 36 1.0× 36 362
Eliza M. Raymundo United States 7 129 0.6× 52 0.5× 23 0.3× 43 1.0× 29 0.8× 14 251
D. Büchser Spain 8 178 0.9× 105 1.0× 15 0.2× 51 1.2× 50 1.4× 31 307
O. Gilliot France 5 180 0.9× 46 0.4× 22 0.3× 48 1.1× 24 0.7× 11 247
Yonghua Yu China 10 144 0.7× 74 0.7× 33 0.5× 71 1.6× 57 1.6× 20 251
Pedro J. Prada Spain 9 369 1.8× 54 0.5× 34 0.5× 51 1.2× 21 0.6× 20 436
Borislav Spajić Croatia 10 157 0.8× 29 0.3× 37 0.5× 73 1.7× 56 1.6× 44 297
Vanessa Moreno United States 8 129 0.6× 63 0.6× 51 0.7× 18 0.4× 27 0.8× 25 235
Alberto D. Hernandez United States 10 219 1.1× 46 0.4× 70 1.0× 153 3.5× 59 1.6× 12 371
Matei Andreoiu United States 4 254 1.3× 21 0.2× 43 0.6× 82 1.9× 31 0.9× 5 322

Countries citing papers authored by Yeşim Sağlıcan

Since Specialization
Citations

This map shows the geographic impact of Yeşim Sağlıcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeşim Sağlıcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeşim Sağlıcan more than expected).

Fields of papers citing papers by Yeşim Sağlıcan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeşim Sağlıcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeşim Sağlıcan. The network helps show where Yeşim Sağlıcan may publish in the future.

Co-authorship network of co-authors of Yeşim Sağlıcan

This figure shows the co-authorship network connecting the top 25 collaborators of Yeşim Sağlıcan. A scholar is included among the top collaborators of Yeşim Sağlıcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeşim Sağlıcan. Yeşim Sağlıcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Doğanca, Tünkut, Mustafa Bilal Tuna, Yeşim Sağlıcan, & Ali Rıza Kural. (2022). Metastasis of Gastric Signet-Ring Cell Carcinoma to the Bladder: An Incidental Finding During Cystoscopy. SHILAP Revista de lepidopterología. 9(3). 218–220.
3.
Karaarslan, Ercan, et al.. (2022). Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.. SHILAP Revista de lepidopterología. 28(1). 12–20. 1 indexed citations
5.
Acar, Ömer, Mert Kılıç, Metin Vural, et al.. (2021). Histologically benign PI‐RADS 4 and 5 lesions contain cancer‐associated epigenetic alterations. The Prostate. 82(1). 145–153. 2 indexed citations
6.
Köseoğlu, Ersin, Mert Kılıç, Dilek Ertoy Baydar, et al.. (2021). The Impact of Visible Tumor (PI-RADS ≥ 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis. Clinical Genitourinary Cancer. 20(1). e61–e67. 6 indexed citations
7.
Vural, Metin, Mert Kılıç, Yeşim Sağlıcan, et al.. (2021). In-bore MRI-guided prostate biopsy in a patient group with PI-RADS 4 and 5 targets: A single center experience. European Journal of Radiology. 141. 109785–109785. 8 indexed citations
8.
Alış, Deniz, et al.. (2021). The visibility of prostate cancer concerning underlying histopathological variances: A single-center multiparametric magnetic resonance imaging study. European Journal of Radiology. 141. 109791–109791. 5 indexed citations
9.
Sağlıcan, Yeşim, et al.. (2020). Suprasellar germinoma with hypopituitarism in an 18-year old man: A case report and review of literature. Clinical Neurology and Neurosurgery. 196. 106026–106026. 3 indexed citations
11.
Sağlıcan, Yeşim, Mustafa Bilal Tuna, David M. Wilson, et al.. (2020). Non-muscle invasive bladder cancer tissues have increased base excision repair capacity. Scientific Reports. 10(1). 16371–16371. 9 indexed citations
12.
Kılıç, Mert, Metin Vural, Ömer Acar, et al.. (2019). Accuracy of Sampling PI-RADS 4–5 Index Lesions Alone by MRI-guided In-bore Biopsy in Biopsy–naive Patients Undergoing Radical Prostatectomy. European Urology Focus. 6(2). 249–254. 12 indexed citations
13.
Kiremit, Murat Can, Ömer Acar, Yeşim Sağlıcan, & Tarık Esen. (2017). Bilateral renal cell carcinoma with leiomyomatous stroma: A rare entity diagnosed synchronously and treated surgically in a staged fashion. SHILAP Revista de lepidopterología. 43(4). 566–570. 3 indexed citations
14.
Öbek, Can, Yeşim Sağlıcan, Ümit İnce, et al.. (2017). Intra-surgical total and re-constructible pathological prostate examination for safer margins and nerve preservation (Istanbul preserve). Annals of Diagnostic Pathology. 33. 35–39. 12 indexed citations
15.
Şahin, Ahmet, et al.. (2017). Association of B7-H4 gene polymorphisms in urothelial bladder cancer. TURKISH JOURNAL OF MEDICAL SCIENCES. 47(2). 443–446. 3 indexed citations
16.
Sağlıcan, Yeşim, et al.. (2016). The first recurrent intravascular papillary endothelial hyperplasia (Masson’s tumor) of the kidney. SHILAP Revista de lepidopterología. 42(3). 202–205. 4 indexed citations
17.
Polat, Şenol, et al.. (2013). Evaluation of Tissue Response to Gore-Tex (Expanded Polytetrafluoroethylene) Implantation. Journal of Craniofacial Surgery. 24(4). 1428–1430. 4 indexed citations
18.
Özcan, Ümit Aksoy, et al.. (2013). Evaluation of testicular tumour calcification with digital orchiography. European Radiology. 23(11). 3178–3184. 1 indexed citations
19.
Deveci, Serkan, et al.. (2012). A Case of Polypoid Cystitis Mimicking Bladder Tumor in Asymptomatic Patient. DergiPark (Istanbul University). 17(3). 176–177. 1 indexed citations
20.
Atış, Gökhan, et al.. (2010). Testicular Polyarteritis Nodosa Mimicking Testicular Neoplasm. The Scientific World JOURNAL. 10. 1915–1918. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026